Blanc P, Rouanet C, Donadio D, Paleirac G, Michel H
Clinique des Maladies de l'appareil digestif, Hôpital Saint-Eloi, Montpellier.
Presse Med. 1990 Mar 10;19(9):416-9.
Protein S is a physiological inhibitor of coagulation. It intervenes as co-factor of activated protein C and increases the inactivation of factors V and VIII induced by the latter. Patients with protein S deficiency are exposed to recurrent venous and arterial thrombosis. Most of these thromboses affect the lower limbs, but other regions, and notably the digestive tract, may be involved. Deficiencies in physiological inhibitors of coagulation, and in particular protein S, seem to be a new entity in the vascular pathology of the gastrointestinal system. All young patients with thromboembolic accidents affecting the digestive tract should be investigated for protein S deficiency. If such deficiency is found, then all members of the patients' family must also be investigated. Long-term treatment with antivitamin K drugs prevents recurrences of these thromboembolic accidents.
蛋白S是一种生理性凝血抑制剂。它作为活化蛋白C的辅因子发挥作用,增强后者对因子V和VIII的灭活作用。蛋白S缺乏的患者易反复发生静脉和动脉血栓形成。这些血栓大多影响下肢,但其他部位,尤其是消化道,也可能受累。凝血生理性抑制剂缺乏,特别是蛋白S缺乏,似乎是胃肠道系统血管病变中的一种新情况。所有发生影响消化道的血栓栓塞事件的年轻患者均应检查是否存在蛋白S缺乏。如果发现此类缺乏,那么患者的所有家庭成员也必须接受检查。使用抗维生素K药物进行长期治疗可预防这些血栓栓塞事件的复发。